You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
Clinical Articles
Br J Cardiol 2012;19:65–9 10.5837/bjc.2012.013
What do angina patients understand of options for myocardial revascularisation?
Patient knowledge and understanding of their condition is important in every field of medicine. It is particularly relevant in cardiology where choices between treatment options
Br J Cardiol 2012;19:71–5 10.5837/bjc.2012.014
Planning for end-of-life care in heart failure: experience of two integrated cardiology-palliative care teams
We previously reported retrospective data on the place of death for people with heart failure (HF) known to heart failure nurse specialists (HFNS) working in
Br J Cardiol 2012;19:76–8 10.5837/bjc.2012.015
Routine follow-up for patients with prosthetic valves: the value of a nurse-led valve clinic
To see whether a nurse-led clinic might be useful we audited how often patients discharged from follow-up were elsewhere seen in the community and how
Br J Cardiol 2012;19:79–84 10.5837/bjc.2012.016
Omega-3 fatty acids in cardiovascular disease: re-assessing the evidence
With conflicting findings from studies of omega-3 fatty acids in cardiovascular disease, many healthcare professionals are uncertain of whether they show any benefit. BJC seminars
Br J Cardiol 2012;19:85–9 10.5837/bjc.2012.017
Drugs for diabetes: part 9 prescribing for patients with cardiac disease
Up to one-third of patients with heart disease have diabetes. Cardiological status should be considered when deciding on treatment for diabetes. Patients with stable coronary
Br J Cardiol 2012;19:90–4 10.5837/bjc.2012.018
Pacemaker complications in a district general hospital
Pacemakers are being implanted with increasing frequency. As with every procedure, there is the potential for complications. There are little recent data on implant complications
Br J Cardiol 2012;19:95–6 10.5837/bjc.2012.019
Post-myocardial infarction (Dressler’s) syndrome following early reperfusion
We present a case of a 55-year-old female with a successfully reperfused myocardial infarction in whom Dressler’s syndrome was subsequently diagnosed. There have been no
Br J Cardiol 2012;19:21–3 10.5837/bjc.2012.001
Optimised beta blocker therapy in heart failure: is there space for additional heart rate control?
The importance of heart rate reduction in chronic stable heart failure (HF) has been highlighted in the recently published Systolic Heart Failure Treatment with If
Br J Cardiol 2012;19:24 10.5837/bjc.2012.003
Current prescribing of statins and persistence to statins following ACS in the UK: a MINAP/GPRD study
National Institute for Health and Clinical Excellence (NICE) guideline CG67 recommends that acute coronary syndrome (ACS) cases are treated with high-intensity statins (defined as statins
Br J Cardiol 2012;19:25 10.5837/bjc.2012.004
Hearing the voice of the heart failure patient: key experiences identified in qualitative interviews
Although morbidity and mortality are the most commonly used end points in clinical trials of heart failure treatments, it is also important to consider how